Common Contracts
2 similar Trans-Pacific Partnership Agreement contracts
Matthew Rimmer*Trans-Pacific Partnership Agreement • May 5th, 2020
The mega-regional agreement, the Trans-Pacific Partnership, put forward a radical model for the regulation of intellectual property and access to medicines across the Pacific Rim. The trade agreement makes reference to the framework established by the TRIPS Agreement 1994, the Doha Declaration on the TRIPS Agreement and Public Health 2001, and the WTO General Council Decision 2003 (which has been incorporated into the TRIPS Agreement 1994 as an amendment in 2017). Nonetheless, it does little to positively advance public health and access to medicines. The Trans-Pacific Partnership seeks to maximize the intellectual property rights of pharmaceutical drug companies. The agreement has extensive provisions on patentable subject matter, patent standards, patent term extensions and evergreening, patent registration linkages and border measures. There has also been controversy over measures related to data protection, the protection of biologics, and trade secrets. The World Health Organizati
Matthew Rimmer*Trans-Pacific Partnership Agreement • April 13th, 2017
The mega-regional agreement, the Trans-Pacific Partnership, put forward a radical model for the regulation of intellectual property and access to medicines across the Pacific Rim. The trade agreement makes reference to the framework established by the TRIPS Agreement 1994, the Doha Declaration on the TRIPS Agreement and Public Health 2001, and the WTO General Council Decision 2003 (which has been incorporated into the TRIPS Agreement 1994 as an amendment in 2017). Nonetheless, it does little to positively advance public health and access to medicines. The Trans-Pacific Partnership seeks to maximize the intellectual property rights of pharmaceutical drug companies. The agreement has extensive provisions on patentable subject matter, patent standards, patent term extensions and evergreening, patent registration linkages and border measures. There has also been controversy over measures related to data protection, the protection of biologics, and trade secrets. The World Health Organizati
